Amedeo Smart

Free Medical Literature Service




  Free Subscription


1 Am J Obstet Gynecol
1 Antiviral Res
1 Clin Infect Dis
5 Infect Control Hosp Epidemiol
2 Int J Infect Dis
2 J Infect
7 J Med Virol
1 J Virol
1 Lancet
1 Lancet Infect Dis
1 N Engl J Med
1 Nature
1 Travel Med Infect Dis

    Am J Obstet Gynecol

  1. BRUNO AM, Sandoval GJ, Hughes BL, Grobman WA, et al
    Postpartum pharmacologic thromboprophylaxis and complications in a US cohort.
    Am J Obstet Gynecol. 2024 Feb 8:S0002-9378(23)00815.
    >> Share

    Antiviral Res

  2. JIAO Z, Wang P, Hu X, Chen Y, et al
    Feline infectious peritonitis virus ORF7a is a virulence factor involved in inflammatory pathology in cats.
    Antiviral Res. 2024;222:105794.
    >> Share


  3. MELLO MM, Jiang D, Platt E, Moran-McCabe K, et al
    Legal infrastructure for pandemic response: lessons not learnt in the US.
    BMJ. 2024;384:e076269.
    >> Share

  4. Seven days in medicine: 31 Jan to 6 Feb 2024.
    BMJ. 2024;384:q299.
    >> Share

    Long covid: Online rehabilitation can improve quality of life, study reports.
    BMJ. 2024;384:q346.
    >> Share

    Clin Infect Dis

  6. HOFMEYER KA, Ventura CL, Armstrong KL, Houchens CR, et al
    Project NexGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future.
    Clin Infect Dis. 2024 Feb 13:ciae073. doi: 10.1093.
    >> Share

    Infect Control Hosp Epidemiol

  7. MOST ZM, Phillips B, Sebert ME
    Healthcare-associated respiratory viral infections after discontinuing universal masking.
    Infect Control Hosp Epidemiol. 2024;45:247-249.
    >> Share

  8. VALEK AL, Srinivasa VR, Ayres AM, Cheung S, et al
    Incidence and transmission associated with respiratory viruses in an acute care facility: An observational study.
    Infect Control Hosp Epidemiol. 2024 Feb 14:1-3. doi: 10.1017/ice.2024.
    >> Share

  9. HOWARD-ANDERSON JR, Gottlieb LB, Beekmann SE, Polgreen PM, et al
    Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey.
    Infect Control Hosp Epidemiol. 2024 Feb 14:1-6. doi: 10.1017/ice.2024.
    >> Share

  10. STROBL R, Misailovski M, Blaschke S, Berens M, et al
    Differentiating patients admitted primarily due to coronavirus disease 2019 (COVID-19) from those admitted with incidentally detected severe acute respiratory syndrome corona-virus type 2 (SARS-CoV-2) at hospital admission: A cohort analysis of German
    Infect Control Hosp Epidemiol. 2024 Feb 14:1-8. doi: 10.1017/ice.2024.
    >> Share

  11. BARTSCH SM, Weatherwax C, Martinez MF, Chin KL, et al
    Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homes.
    Infect Control Hosp Epidemiol. 2024 Feb 15:1-8. doi: 10.1017/ice.2024.
    >> Share

    Int J Infect Dis

  12. DOHERTY TM, Pasquale AD, Finnegan G, Lele J, et al
    Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: a scoping review.
    Int J Infect Dis. 2024 Feb 12:S1201-9712(24)00031.
    >> Share

  13. TANG Q, Xie X, Peng L, Yang L, et al
    Pre-existing Renal Graft Dysfunction As A Major Risk Factor for SARS-CoV-2 Omicron Variant Pneumonia: a Post-Infection Cross-Sectional Study of 312 Immunosuppressed Renal Transplant Recipients.
    Int J Infect Dis. 2024 Feb 13:S1201-9712(24)00030.
    >> Share

    J Infect

  14. XIE L, Luo G, Yang Z, Wu WC, et al
    The clinical outcome of COVID-19 is strongly associated with microbiome dynamics in the upper respiratory tract.
    J Infect. 2024 Feb 9:S0163-4453(24)00036-7. doi: 10.1016/j.jinf.2024.
    >> Share

  15. KALKERI R, Zhu M, Cloney-Clark S, Plested JS, et al
    Altered IgG4 Antibody Response to Repeated mRNA versus Recombinant Protein SARS-CoV-2 Vaccines.
    J Infect. 2024 Feb 13:106119. doi: 10.1016/j.jinf.2024.106119.
    >> Share

    J Med Virol

  16. ZENG G, Zhang Z, Wang L, Li J, et al
    Risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients.
    J Med Virol. 2023;95:e29235.
    >> Share

  17. ZHAN H, Xie Y, Liu Y, Cheng L, et al
    Omicron BA.4/5 neutralization and cell-mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: A follow-up cohort study.
    J Med Virol. 2024;96:e29446.
    >> Share

  18. KIM D, Kim M, Kim J, Baek K, et al
    A mouse xenograft long-term replication yields a SARS-CoV-2 Delta mutant with increased lethality.
    J Med Virol. 2024;96:e29459.
    >> Share

  19. KWOK KO, Wei WI, Mcneil EB, Tang A, et al
    Comparative analysis of symptom profile and risk of death associated with infection by SARS-CoV-2 and its variants in Hong Kong.
    J Med Virol. 2024;96:e29326.
    >> Share

  20. CENAT JM, Farahi SMMM, Dalexis RD, Yaya S, et al
    COVID-19 vaccine uptake, conspiracy theories, and health literacy among Black individuals in Canada: Racial discrimination, confidence in health, and COVID-19 stress as mediators.
    J Med Virol. 2024;96:e29467.
    >> Share

  21. SADAT LARIJANI M, Javadi A, Eskandari SE, Doroud D, et al
    The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID-19 vaccine regimens.
    J Med Virol. 2024;96:e29438.
    >> Share

  22. COLSON P, Delerce J, Pontarotti P, Devaux C, et al
    Resistance-associated mutations to the anti-SARS-CoV-2 agent nirmatrelvir: Selection not induction.
    J Med Virol. 2024;96:e29462.
    >> Share

    J Virol

  23. LI Z, Lai Y, Qiu R, Tang W, et al
    Hyperacetylated microtubules assist porcine deltacoronavirus nsp8 to degrade MDA5 via SQSTM1/p62-dependent selective autophagy.
    J Virol. 2024 Feb 14:e0000324. doi: 10.1128/jvi.00003.
    >> Share


  24. RUBIN R
    When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not All Alike.
    JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
    >> Share


  25. WALLER BY, Joseph VA, Keyes KM
    Racial inequities in homicide rates and homicide methods among Black and White women aged 25-44 years in the USA, 1999-2020: a cross-sectional time series study.
    Lancet. 2024 Feb 8:S0140-6736(23)02279-1. doi: 10.1016/S0140-6736(23)02279.
    >> Share

    Lancet Infect Dis

  26. MACHKOVECH HM, Hahn AM, Garonzik Wang J, Grubaugh ND, et al
    Persistent SARS-CoV-2 infection: significance and implications.
    Lancet Infect Dis. 2024 Feb 7:S1473-3099(23)00815.
    >> Share

    N Engl J Med

  27. VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al
    Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
    N Engl J Med. 2024;390:589-600.
    >> Share


  28. The immune markers that predict who can keep SARS-CoV-2 in check.
    Nature. 2024 Feb 13. doi: 10.1038/d41586-024-00411.
    >> Share

    Travel Med Infect Dis

  29. GAGLIARDINI R, Giacomelli A, Bozzi G, D'Arminio Monforte A, et al
    Impact of COVID-19 pandemic on retention in care of native and migrant people with HIV in the ICONA cohort.
    Travel Med Infect Dis. 2024;58:102691.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016